Skip to main content

Advertisement

SpringerLink
Log in

A practical guide to the management of menopausal symptoms in breast cancer patients

  • Review Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Breast cancer is the most frequently diagnosed cancer in Canadian women. As a result of increased screening and improved treatment, more women are becoming long-term breast cancer survivors. However, due to either their treatment or prolonged survival, many of these women now have to face the consequences of premature menopause and prolonged estrogen deprivation. Hormone replacement therapy/estrogen replacement therapy (HRT/ERT) has, in the past, been recommended to healthy women at menopause not only for relief of short-term menopausal changes, particularly hot flashes, but also for its benefits on bone density, fracture reduction, and genitourinary symptoms. Recent studies have demonstrated that not only is HRT associated with an increased risk of developing breast cancer, but it also has been shown to increase the risk of recurrence in those with a breast cancer history. Until the safety of HRT/ERT in breast cancer patients can be more fully clarified, it would be wise to develop alternative strategies for the management of menopausal symptoms in these patients. This paper will discuss nonestrogen-based therapies for hot flashes, osteoporosis, and genitourinary symptoms, with emphasis on efficacy and safety in breast cancer survivors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288:321–333

    Google Scholar 

  2. Shumaker SA, Legault C, Rapp SR et al (2003) Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2651–2662

    Article  CAS  PubMed  Google Scholar 

  3. The Women’s Health Initiative Steering Committee (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative Randomized Controlled Trial. JAMA 291:1701–1712

    Google Scholar 

  4. Holmberg L, Anderson H, for the HABITS Steering and Data Monitoring Committees (2004) HABITS (Hormonal Replacement Therapy After Breast Cancer—is it safe?), a randomized comparison: trial stopped. Lancet 363:453–455

    Article  CAS  PubMed  Google Scholar 

  5. Ganz PA, Greendale GA, Peterson L et al (2000) Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. J Natl Cancer Inst 92:1054–1064

    Google Scholar 

  6. Loprinzi CL, Michalak JC, Quella SK et al (1994) Megestrol acetate for the prevention of hot flashes. N Engl J Med 331:347–352

    Article  CAS  PubMed  Google Scholar 

  7. Quella SK, Loprinzi CL, Sloan JA et al (1998) Long-term use of megestrol acetate for treatment of hot flashes in cancer survivors. Cancer 82:1784–1788

    Google Scholar 

  8. Eden J (2003) Progestins and breast cancer. Am J Obstet Gynecol 188:1123–1131

    Article  CAS  PubMed  Google Scholar 

  9. Million Women Study Collaborators (2003) Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 362:419–427

    Google Scholar 

  10. Modelska K, Cummins S (2002) Tibolone for postmenopausal women: systematic review of randomized trials. J Clin Endocrinol Metab 87:16–23

    Article  CAS  PubMed  Google Scholar 

  11. Loprinzi CL, Kugler JW, Sloan JA et al (2000) Venlafaxine in management of hot flashes in survivors of breast cancer: a randomized controlled trial. Lancet 356:2059–2063

    CAS  PubMed  Google Scholar 

  12. Barton D, La VB, Loprinzi C et al (2002) Venlafaxine for the control of hot flashes: results of a longitudinal continuation study. Oncol Nurs Forum 29:33–40

    PubMed  Google Scholar 

  13. Loprinzi CL, Sloan JA, Perez E et al (2002) Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 20(6):1578–1583

    Article  CAS  PubMed  Google Scholar 

  14. Stearns V, Beebe KL, Iyengar M et al (2003) Paroxetine controlled release in the treatment of menopausal hot flashes—a randomized controlled trial. JAMA 289:2827–2834

    CAS  PubMed  Google Scholar 

  15. Pandya KJ, Thummala AR, Griggs JJ et al (2004) Pilot study using gabapentin for tamoxifen-induced hot flashes in women with breast cancer. Breast Cancer Res Treat 83:87–89

    Google Scholar 

  16. Struble E, Dice Y, Ornstein DL et al (2004) Gabapentin versus venlafaxine for the treatment of menopausal symptoms: a preliminary report. Breast Cancer Res Treat 88(Suppl 1):240–241 (abstract# 6061)

    Google Scholar 

  17. Goldberg RM, Loprinzi CL, O’Fallon JR et al (1994) Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol 12:155–158

    CAS  PubMed  Google Scholar 

  18. Pandya KJ, Raubertas RF, Flynn PJ et al (2000) Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program Study. Ann Intern Med 132:788–793

    CAS  PubMed  Google Scholar 

  19. Barton DL, Loprinzi CL, Quella SK et al (1998) Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 16:495–500

    CAS  PubMed  Google Scholar 

  20. Miller ER, Pastor-Barriuso R, Dalal D et al (2005) Meta-analysis: high dose vitamin E supplementation may increase all cause mortality. Ann Intern Med 142:37–46

    PubMed  Google Scholar 

  21. Kessel B, Kronenberg F (2004) The role of complimentary and alternative medicine in management of menopausal symptoms. Endocrinol Metab Clin N Am 33:717–739

    Article  CAS  Google Scholar 

  22. Quella SK, Loprinzi CL, Barton D et al (2000) Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Treatment Group Trial. J Clin Oncol 18:1068–1074

    CAS  PubMed  Google Scholar 

  23. Van Patten CL, Olivotto IO, Chambers GK et al (2002) Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized controlled clinical trial. J Clin Oncol 20:1449–1455

    Article  PubMed  Google Scholar 

  24. Jacobson JS, Troxel AB, Evans J et al (2001) Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 19:2739–2745

    CAS  PubMed  Google Scholar 

  25. Kurzer M (2003) Phytoestrogen supplement use by women. J Nutr 133:1983s–1986s

    PubMed  Google Scholar 

  26. Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929–1936

    PubMed  Google Scholar 

  27. Hillner BE, Ingle JN, Chlebowski R et al (2003) American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 21:4042–4057

    CAS  PubMed  Google Scholar 

  28. Fleisch H (2003) Bisphosphonates in osteoporosis. Eur Spine J 12:S142–S146

    Google Scholar 

  29. Kerarnopopoullos A, Gaki V, Baltas D et al (2003) Stopping tamoxifen after 5 years. What’s next? Breast 12:S40–S41 (Abstract P92)

    Article  Google Scholar 

  30. The ATAC Trialists’ Group (2003) Anastrazole alone or in combination with tamoxifen vs tamoxifen alone for adjuvant treatment of postmenopausal women with early stage breast cancer. Results Of the ATAC trial efficacy and safety update analysis. Cancer 98:1802–1810

    Google Scholar 

  31. Bachmann GA, Leiblum SR (2004) The impact of hormones on menopausal sexuality: a literature review. Menopause 11:120–130

    Article  PubMed  Google Scholar 

  32. Somboonporn W, Davis S (2004) Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev 25:374–388

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Medical Oncology, Sunnybrook & Women’s College Health Sciences Centre, University of Toronto, Toronto, Canada

    M. C. Gainford, C. Simmons, S. Verma & M. Clemons

  2. Hotel Dieu Family Medicine Centre, Queen’s University, Kingston, Ontario, Canada

    H. Nguyen

Authors
  1. M. C. Gainford
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Simmons
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Nguyen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Verma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Clemons
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Clemons.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gainford, M.C., Simmons, C., Nguyen, H. et al. A practical guide to the management of menopausal symptoms in breast cancer patients. Support Care Cancer 13, 573–578 (2005). https://doi.org/10.1007/s00520-005-0847-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-005-0847-y

Keywords

Search

Navigation